Home health remedies Digital video takes over as the new—and cheaper—TV advertising for pharma

Digital video takes over as the new—and cheaper—TV advertising for pharma

4
0
SHARE

Did video kill the TV star in 2020? Not exactly, but it’s definitely making marketers rethink traditional TV viewing and advertising models.

Pharma marketers and agencies, even those with big budgets, are embracing digital video as not only a less costly alternative to mainstream TV buys but also as a way to target and engage increasingly fractured audiences when and where they want to watch something. Digital video also doesn’t come with a 30-second time limit, which allows for more in-depth storytelling.

“We don’t all consume the same live TV programming or even streaming services anymore,” Leigh Householder, managing director of insights and innovation at Syneos Health, said.

Upcoming Webinar

Strategies for the Optimal Scale-up & Tech Transfer of Oral Small Molecules

The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Join this webinar to hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program. Register Today!

RELATED: Fierce Pharma Marketing tees up trends for 2021—and big news, they’re not all COVID-related

She pointed to two trends fueling the growth and changes with digital video: personal prime time, or the individual content any person watches that creates a kind of TV channel for one, and programmatic relevance, where artificially intelligent tools can match content to the viewers who value it.

“When you put the two together, you find—I wouldn’t even call it a channel—but an entirely new way to connect with people that’s very effective and affordable,” she said.

Viewers are watching digital pharma ads everywhere. A mid-year study found mobile as the top spot with 47% of people viewing there, according to video ad tech company Innovid. However, connected TV wasn’t far behind at 37%, which was a jump over last year’s more typical highs in the upper 20 percentiles.

 

TV advertising will certainly continue to be a vehicle for pharma marketers; they’re once again set for yearly spending of around $4 billion on national TV commercial media. However, TV is also changing, with marketers turning to addressable options that allow them to deliver different ads to different households during the same programming.

RELATEDPharma video ads surge after initial COVID-19 slowdown, adtech company tracks significant year-over-year growth

As Susan Perlbachs, chief creative officer at Intouch Group, said in its 2021 trend report, “These days, it’s more accurate to simply call TV ‘video.’ Linear [traditional] TV couldn’t be optimized; it was ‘spray and pray.’ Now, with addressable TV, television has become just another screen, and channel to deliver customized content and forge the same connections as with programmatic.”

“I love letting clients know how affordable TV is today,” Perlbachs said, “even for rare disease brands, which are in desperate need of personalized, relevant connections.”

Source link